Expertise in
2
conditions

Dr. Karen S. Mccoy

Pediatric Pulmonology
Nationwide Children's Hospital
700 Childrens Dr, 
Columbus, OH 
Accepting New Patients
Expertise in
2
conditions
Nationwide Children's Hospital
700 Childrens Dr, 
Columbus, OH 

Overview

Karen Mccoy is a Pediatric Pulmonologist practicing medicine in Columbus, Ohio.

Dr. Mccoy is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Cystic Fibrosis, Asthma, Secondary Immunodeficiency (SID), Pseudomonas Stutzeri Infections, and Lung Transplant.

She is actively involved in clinical research, co-authoring 84 peer reviewed articles and participating in 8 clinical trials. Dr. Mccoy is currently accepting new patients.

Specialties

Pediatric Pulmonology

Licenses

Pediatric Pulmonology in OH

Hospital Affiliations

Nationwide Children's Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Mutual
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Ohio Health Group
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Nationwide Children's Hospital
700 Childrens Dr, Columbus, OH 43205
Other Locations
Office
555 S 18th St, Columbus, OH 43205

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Multi-Center Study of Non-Invasive Colorectal Cancer Evaluation in Cystic Fibrosis (NICE-CF)
A Multi-Center Study of Non-Invasive Colorectal Cancer Evaluation in Cystic Fibrosis (NICE-CF)
Enrollment Status: Active_not_recruiting
Publish Date: March 24, 2026
Intervention Type: Procedure
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
Enrollment Status: Unknown
Publish Date: April 02, 2024
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
Enrollment Status: Unknown
Publish Date: April 02, 2024
A Phase 1b/2a, Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of AP-PA02 Multi-Phage Therapeutic Candidate for Inhalation in Subjects With Cystic Fibrosis and Chronic Pulmonary Pseudomonas Aeruginosa (Pa) Infection
A Phase 1b/2a, Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of AP-PA02 Multi-Phage Therapeutic Candidate for Inhalation in Subjects With Cystic Fibrosis and Chronic Pulmonary Pseudomonas Aeruginosa (Pa) Infection
Enrollment Status: Completed
Publish Date: January 31, 2024
Intervention Type: Other, Biological
Study Drug: AP-PA02 Bacteriophage
Study Phase: Phase 1/Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis
Enrollment Status: Completed
Publish Date: January 18, 2023
Intervention Type: Drug, Other
Study Drug: Lenabasum
Study Phase: Phase 2
A Phase III, Randomized, Double-blind, Placebo-controlled Study of AeroVanc for the Treatment of Persistent Methicillin-resistant Staphylococcus Aureus Lung Infection in Cystic Fibrosis Patients
A Phase III, Randomized, Double-blind, Placebo-controlled Study of AeroVanc for the Treatment of Persistent Methicillin-resistant Staphylococcus Aureus Lung Infection in Cystic Fibrosis Patients
Enrollment Status: Completed
Publish Date: December 16, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2 Open Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dose Levels of Subcutaneously Administered ELX-02 in Patients With Cystic Fibrosis With at Least One G542X Allele
A Phase 2 Open Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dose Levels of Subcutaneously Administered ELX-02 in Patients With Cystic Fibrosis With at Least One G542X Allele
Enrollment Status: Completed
Publish Date: November 22, 2022
Intervention Type: Drug
Study Drug: ELX-02 Ribosomal-Selective Glycoside
Study Phase: Phase 2
Phase 1b, Randomized, Double-blind, Placebo-controlled, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of QR-010 in Subjects With Homozygous ΔF508 Cystic Fibrosis
Phase 1b, Randomized, Double-blind, Placebo-controlled, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of QR-010 in Subjects With Homozygous ΔF508 Cystic Fibrosis
Enrollment Status: Completed
Publish Date: February 06, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 7 Less Clinical Trials

84 Total Publications

Real-world efficacy, safety and heterogenicity of efficacy of elexacaftor-tezacaftor-ivacaftor in younger children (6-11 years old) with cystic fibrosis.
Real-world efficacy, safety and heterogenicity of efficacy of elexacaftor-tezacaftor-ivacaftor in younger children (6-11 years old) with cystic fibrosis.
Journal: Respiratory medicine
Published: April 06, 2026
Similar Doctors
Expertise in
4
conditions
Dr. Kavitha Kotha
Pediatric Pulmonology
Expertise in
4
conditions
Dr. Kavitha Kotha
Pediatric Pulmonology
Referral may be required

Nationwide Children's Hospital

700 Childrens Dr, 
Columbus, OH 
 (0.1 miles away)
614-722-4750
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Kavitha Kotha is a Pediatric Pulmonologist practicing medicine in Columbus, Ohio. Dr. Kotha is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Cystic Fibrosis, Secondary Immunodeficiency (SID), Duchenne Muscular Dystrophy, and Spinal Muscular Atrophy Type 2. Dr. Kotha is currently accepting new patients.

Expertise in
3
conditions
Dr. Shahid I. Sheikh
Pediatric Pulmonology
Expertise in
3
conditions
Dr. Shahid I. Sheikh
Pediatric Pulmonology
Referral may be required

Nationwide Children's Hospital

700 Childrens Dr, 
Columbus, OH 
 (0.1 miles away)
614-722-2180
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Shahid Sheikh is a Pediatric Pulmonologist practicing medicine in Columbus, Ohio. Dr. Sheikh is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Cystic Fibrosis, Asthma, Bronchopulmonary Dysplasia, Short Rib-Polydactyly Syndrome Type 1, and Lung Transplant. Dr. Sheikh is currently accepting new patients.

Expertise in
4
conditions
Dr. John S. Heintz
Pediatric Pulmonology | Pediatrics
Expertise in
4
conditions
Dr. John S. Heintz
Pediatric Pulmonology | Pediatrics
Referral may be required
150 W Main St, 
New Albany, OH 
 (12.5 miles away)
614-722-2000
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

John Heintz is a Pediatric Pulmonologist and a Pediatrics provider practicing medicine in New Albany, Ohio. Dr. Heintz is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Secondary Immunodeficiency (SID), Cystic Fibrosis, Newborn Jaundice, and Jaundice. Dr. Heintz is currently accepting new patients.

Frequently Asked Questions about Dr. Karen S. Mccoy

How do I make an appointment with Dr. Karen S. Mccoy?

You can book an appointment with Dr. Karen S. Mccoy by calling their office at 614-722-4766. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Karen S. Mccoy a top-rated expert for Cystic Fibrosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Karen S. Mccoy is classified as an Elite expert for Cystic Fibrosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Karen S. Mccoy specialize in?

While Dr. Karen S. Mccoy is a Pediatric Pulmonology, they have specific expertise in Cystic Fibrosis, Asthma, and Secondary Immunodeficiency (SID). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Pulmonology.

Does Dr. Karen S. Mccoy participate in research or clinical trials?

Yes. Dr. Karen S. Mccoy has published 84 articles and abstracts on conditions like Cystic Fibrosis. You can view a list of Dr. Karen S. Mccoy's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Karen S. Mccoy accept my insurance?

Dr. Karen S. Mccoy accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 614-722-4766 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mccoy's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile